TipRanks
Mannkind Corp. (CH:NNFN)
:NNFN
Switzerland Market

MannKind (NNFN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

NNFN Analyst Ratings

Strong Buy
8Ratings
Strong Buy
7 Buy
1 Hold
0 Sell
Based on 8 analysts giving stock ratings to
MannKind
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NNFN Stock 12 Month Forecast

Average Price Target

―
Based on 8 Wall Street analysts offering 12 month price targets for MannKind in the last 3 months. The average price target is CHF6.49 with a high forecast of CHF10.74 and a low forecast of CHF3.44. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"CHF2","11":"CHF11","4.25":"CHF4.25","6.5":"CHF6.5","8.75":"CHF8.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10.73585175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF10.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.494158015312499,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF6.49</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.43547256,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF3.44</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,4.25,6.5,8.75,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.393,3.95783475,4.5226695,5.08750425,5.652339,6.217173750000001,6.7820085,7.34684325,7.911678,8.476512750000001,9.0413475,9.60618225,10.171016999999999,{"y":10.73585175,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.393,3.6315506165624996,3.8701012331249998,4.1086518496875,4.34720246625,4.5857530828124995,4.824303699374999,5.0628543159375,5.3014049325,5.539955549062499,5.778506165624999,6.017056782187499,6.25560739875,{"y":6.494158015312499,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.393,3.3962671199999996,3.39953424,3.4028013599999998,3.40606848,3.4093356,3.4126027199999998,3.41586984,3.41913696,3.4224040799999997,3.4256712,3.42893832,3.43220544,{"y":3.43547256,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.393,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.393,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF10.74Average Price TargetCHF6.49Lowest Price TargetCHF3.44
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Chardan Capital Analyst forecast on CH:NNFN
Chardan Capital
Chardan Capital
CHF8.26
Buy
―
Initiated
10/19/26
MannKind initiated with a Buy at ChardanMannKind initiated with a Buy at Chardan
Cantor Fitzgerald Analyst forecast on CH:NNFN
Cantor Fitzgerald
Cantor Fitzgerald
CHF6.61
Buy
―
Reiterated
10/19/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: EyePoint Pharmaceuticals (NASDAQ: EYPT), MannKind (NASDAQ: MNKD) and Disc Medicine (NASDAQ: IRON)
Wells Fargo Analyst forecast on CH:NNFN
Wells Fargo
Wells Fargo
CHF10.74
Buy
―
Reiterated
10/19/26
Analysts Are Bullish on Top Healthcare Stocks: Xencor (XNCR), MannKind (MNKD)
Truist Financial Analyst forecast on CH:NNFN
Truist Financial
Truist Financial
CHF4.96→CHF4.13
Buy
―
Reiterated
10/08/26
Truist Financial Keeps Their Buy Rating on MannKind (MNKD)
H.C. Wainwright Analyst forecast on CH:NNFN
H.C. Wainwright
H.C. Wainwright
CHF8.26
Buy
―
Reiterated
09/21/26
H.C. Wainwright Keeps Their Buy Rating on MannKind (MNKD)
Leerink Partners Analyst forecast on CH:NNFN
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
CHF3.44
Buy
―
Reiterated
09/10/26
Leerink Partners Sticks to Their Buy Rating for MannKind (MNKD)
RBC Capital Analyst forecast on CH:NNFN
RBC Capital
RBC Capital
CHF3.92
Hold
―
Reiterated
08/06/26
RBC Capital Sticks to Their Hold Rating for MannKind (MNKD)
Wedbush Analyst forecast on CH:NNFN
Wedbush
Wedbush
CHF6.61
Buy
―
Reiterated
08/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (NYSE: LLY), MannKind (NASDAQ: MNKD) and Evolus (NASDAQ: EOLS)
Mizuho Securities Analyst forecast on CH:NNFN
Mizuho Securities
Mizuho Securities
CHF6.61→CHF5.78
Buy
―
Reiterated
05/07/26
MannKind price target lowered to $7 from $8 at MizuhoMannKind price target lowered to $7 from $8 at Mizuho
Raymond James Analyst forecast on CH:NNFN
Raymond James
Raymond James
CHF6.61→CHF5.78
Buy
―
Reiterated
02/27/26
MannKind price target lowered to $7 from $8 at Wells FargoMannKind price target lowered to $7 from $8 at Wells Fargo
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Chardan Capital Analyst forecast on CH:NNFN
Chardan Capital
Chardan Capital
CHF8.26
Buy
―
Initiated
10/19/26
MannKind initiated with a Buy at ChardanMannKind initiated with a Buy at Chardan
Cantor Fitzgerald Analyst forecast on CH:NNFN
Cantor Fitzgerald
Cantor Fitzgerald
CHF6.61
Buy
―
Reiterated
10/19/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: EyePoint Pharmaceuticals (NASDAQ: EYPT), MannKind (NASDAQ: MNKD) and Disc Medicine (NASDAQ: IRON)
Wells Fargo Analyst forecast on CH:NNFN
Wells Fargo
Wells Fargo
CHF10.74
Buy
―
Reiterated
10/19/26
Analysts Are Bullish on Top Healthcare Stocks: Xencor (XNCR), MannKind (MNKD)
Truist Financial Analyst forecast on CH:NNFN
Truist Financial
Truist Financial
CHF4.96→CHF4.13
Buy
―
Reiterated
10/08/26
Truist Financial Keeps Their Buy Rating on MannKind (MNKD)
H.C. Wainwright Analyst forecast on CH:NNFN
H.C. Wainwright
H.C. Wainwright
CHF8.26
Buy
―
Reiterated
09/21/26
H.C. Wainwright Keeps Their Buy Rating on MannKind (MNKD)
Leerink Partners Analyst forecast on CH:NNFN
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
CHF3.44
Buy
―
Reiterated
09/10/26
Leerink Partners Sticks to Their Buy Rating for MannKind (MNKD)
RBC Capital Analyst forecast on CH:NNFN
RBC Capital
RBC Capital
CHF3.92
Hold
―
Reiterated
08/06/26
RBC Capital Sticks to Their Hold Rating for MannKind (MNKD)
Wedbush Analyst forecast on CH:NNFN
Wedbush
Wedbush
CHF6.61
Buy
―
Reiterated
08/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (NYSE: LLY), MannKind (NASDAQ: MNKD) and Evolus (NASDAQ: EOLS)
Mizuho Securities Analyst forecast on CH:NNFN
Mizuho Securities
Mizuho Securities
CHF6.61→CHF5.78
Buy
―
Reiterated
05/07/26
MannKind price target lowered to $7 from $8 at MizuhoMannKind price target lowered to $7 from $8 at Mizuho
Raymond James Analyst forecast on CH:NNFN
Raymond James
Raymond James
CHF6.61→CHF5.78
Buy
―
Reiterated
02/27/26
MannKind price target lowered to $7 from $8 at Wells FargoMannKind price target lowered to $7 from $8 at Wells Fargo
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
OVIDOvid Therapeutics
OMCLOmnicell
IMUXImmunic
HITIHigh Tide
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MannKind

3 Months
Brandon FolkesH.C. Wainwright
Success Rate
11/21 ratings generated profit
52%
Average Return
+9.06%
Copying Brandon Folkes's trades and holding each position for 3 Months would result in 52.38% of your transactions generating a profit, with an average return of +9.06% per trade.
1 Year
Brandon FolkesH.C. Wainwright
Success Rate
6/21 ratings generated profit
29%
Average Return
+0.68%
Copying Brandon Folkes's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of +0.68% per trade.
2 Years
Brandon FolkesH.C. Wainwright
Success Rate
6/21 ratings generated profit
29%
Average Return
+13.12%
Copying Brandon Folkes's trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of +13.12% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NNFN Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
13
16
14
15
12
Buy
1
2
2
3
3
Hold
3
2
2
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
20
18
20
16
In the current month, NNFN has received 15 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NNFN average Analyst price target in the past 3 months is 6.49.
Each month's total comprises the sum of three months' worth of ratings.

NNFN Financial Forecast

NNFN Earnings Forecast

Next quarter’s earnings estimate for NNFN is -CHF0.05 with a range of -CHF0.08 to -CHF0.02. The previous quarter’s EPS was -CHF0.05. NNFN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year NNFN has Performed in-line its overall industry.
Next quarter’s earnings estimate for NNFN is -CHF0.05 with a range of -CHF0.08 to -CHF0.02. The previous quarter’s EPS was -CHF0.05. NNFN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year NNFN has Performed in-line its overall industry.

NNFN Sales Forecast

Next quarter’s sales forecast for NNFN is CHF88.97M with a range of CHF81.76M to CHF97.45M. The previous quarter’s sales results were CHF90.32M. NNFN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year NNFN has Performed in-line its overall industry.
Next quarter’s sales forecast for NNFN is CHF88.97M with a range of CHF81.76M to CHF97.45M. The previous quarter’s sales results were CHF90.32M. NNFN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year NNFN has Performed in-line its overall industry.

NNFN Stock Forecast FAQ

What is CH:NNFN’s average 12-month price target, according to analysts?
Based on analyst ratings, Mannkind Corp.’s 12-month average price target is 6.49.
    What is CH:NNFN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:NNFN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Mannkind Corp. a Buy, Sell or Hold?
        Mannkind Corp. has a consensus rating of Strong Buy, which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Mannkind Corp.’s share price target?
          The average share price target for Mannkind Corp. is 6.49. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF10.74 ,and the lowest forecast is CHF3.44. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Mannkind Corp.?
            Mannkind Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
              How can I buy shares of Mannkind Corp.?
              To buy shares of CH:NNFN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.